Cargando…
Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632233/ https://www.ncbi.nlm.nih.gov/pubmed/34858195 http://dx.doi.org/10.3389/fphar.2021.796551 |
_version_ | 1784607718316703744 |
---|---|
author | Shi, Hongwei Tang, Heng Ai, Wen Zeng, Qingfu Yang, Hong Zhu, Fengqing Wei, Yunjie Feng, Rui Wen, Li Pu, Peng He, Quan |
author_facet | Shi, Hongwei Tang, Heng Ai, Wen Zeng, Qingfu Yang, Hong Zhu, Fengqing Wei, Yunjie Feng, Rui Wen, Li Pu, Peng He, Quan |
author_sort | Shi, Hongwei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8632233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86322332021-12-01 Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis Shi, Hongwei Tang, Heng Ai, Wen Zeng, Qingfu Yang, Hong Zhu, Fengqing Wei, Yunjie Feng, Rui Wen, Li Pu, Peng He, Quan Front Pharmacol Pharmacology Frontiers Media S.A. 2021-11-11 /pmc/articles/PMC8632233/ /pubmed/34858195 http://dx.doi.org/10.3389/fphar.2021.796551 Text en Copyright © 2021 Shi, Tang, Ai, Zeng, Yang, Zhu, Wei, Feng, Wen, Pu and He. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Shi, Hongwei Tang, Heng Ai, Wen Zeng, Qingfu Yang, Hong Zhu, Fengqing Wei, Yunjie Feng, Rui Wen, Li Pu, Peng He, Quan Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis |
title | Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis |
title_full | Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis |
title_fullStr | Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis |
title_full_unstemmed | Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis |
title_short | Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis |
title_sort | corrigendum: schisandrin b antagonizes cardiotoxicity induced by pirarubicin by inhibiting mitochondrial permeability transition pore (mptp) opening and decreasing cardiomyocyte apoptosis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632233/ https://www.ncbi.nlm.nih.gov/pubmed/34858195 http://dx.doi.org/10.3389/fphar.2021.796551 |
work_keys_str_mv | AT shihongwei corrigendumschisandrinbantagonizescardiotoxicityinducedbypirarubicinbyinhibitingmitochondrialpermeabilitytransitionporemptpopeninganddecreasingcardiomyocyteapoptosis AT tangheng corrigendumschisandrinbantagonizescardiotoxicityinducedbypirarubicinbyinhibitingmitochondrialpermeabilitytransitionporemptpopeninganddecreasingcardiomyocyteapoptosis AT aiwen corrigendumschisandrinbantagonizescardiotoxicityinducedbypirarubicinbyinhibitingmitochondrialpermeabilitytransitionporemptpopeninganddecreasingcardiomyocyteapoptosis AT zengqingfu corrigendumschisandrinbantagonizescardiotoxicityinducedbypirarubicinbyinhibitingmitochondrialpermeabilitytransitionporemptpopeninganddecreasingcardiomyocyteapoptosis AT yanghong corrigendumschisandrinbantagonizescardiotoxicityinducedbypirarubicinbyinhibitingmitochondrialpermeabilitytransitionporemptpopeninganddecreasingcardiomyocyteapoptosis AT zhufengqing corrigendumschisandrinbantagonizescardiotoxicityinducedbypirarubicinbyinhibitingmitochondrialpermeabilitytransitionporemptpopeninganddecreasingcardiomyocyteapoptosis AT weiyunjie corrigendumschisandrinbantagonizescardiotoxicityinducedbypirarubicinbyinhibitingmitochondrialpermeabilitytransitionporemptpopeninganddecreasingcardiomyocyteapoptosis AT fengrui corrigendumschisandrinbantagonizescardiotoxicityinducedbypirarubicinbyinhibitingmitochondrialpermeabilitytransitionporemptpopeninganddecreasingcardiomyocyteapoptosis AT wenli corrigendumschisandrinbantagonizescardiotoxicityinducedbypirarubicinbyinhibitingmitochondrialpermeabilitytransitionporemptpopeninganddecreasingcardiomyocyteapoptosis AT pupeng corrigendumschisandrinbantagonizescardiotoxicityinducedbypirarubicinbyinhibitingmitochondrialpermeabilitytransitionporemptpopeninganddecreasingcardiomyocyteapoptosis AT hequan corrigendumschisandrinbantagonizescardiotoxicityinducedbypirarubicinbyinhibitingmitochondrialpermeabilitytransitionporemptpopeninganddecreasingcardiomyocyteapoptosis |